ROHINA AHMED: Open Payments
NPI 1770364861 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 70 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $1,616
Food & beverage: $1,616
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $294 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| ABBVIE INC. | 9 | $175 |
| PFIZER INC. | 8 | $171 |
| Lilly USA, LLC | 6 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| ACADIA Pharmaceuticals Inc | 3 | $64 |
| Exact Sciences Corporation | 2 | $58 |
Products named: Wegovy, NURTEC ODT, Ozempic, FARXIGA, CAPLYTA, VRAYLAR, TRINTELLIX, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
